Next, to examine the effects of BMS309403—a chemical inhibitor of FABP4—on HF-induced TRAMP tumorigenesis, 8-week-old TRAMP mice were randomly assigned to three groups: TRAMP-CD (n = 8), TRAMP-HF (n = 11), and HF with BMS309403 administration at 40 μg/mL (TRAMP-HF + BMS, n = 12) groups. The gene discussed is FABP4; the disease is hydrops fetalis.